Jordan vs United Arab Emirates: Share of E. coli infections resistant to cephalosporins
Jordan
57.2%
in 2022
United Arab Emirates
52.4%
in 2022
Jordan rank
14th
United Arab Emirates rank
17th
Share of E. coli infections resistant to cephalosporins over time
- Jordan
- United Arab Emirates
How they compare
Jordan currently reports 57.2% against 52.4% in United Arab Emirates, a difference of 4.8%.
That makes Jordan's figure about 1.1 times United Arab Emirates's.
Across all 5 years both countries report, Jordan has been ahead every year.
Jordan ranks 14th and United Arab Emirates ranks 17th of 46 countries.
Jordan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Jordan | United Arab Emirates | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 64.3% | 47.3% | 17.0% | Jordan |
| 2020s | 60.7% | 52.7% | 8.0% | Jordan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of e. coli infections resistant to cephalosporins, Jordan or United Arab Emirates?
- Jordan, at 57.2% against 52.4% in United Arab Emirates as of 2022.
- What is the difference in share of e. coli infections resistant to cephalosporins between Jordan and United Arab Emirates?
- 4.8%, with Jordan ahead.
- How many years of comparable data are there for Jordan and United Arab Emirates?
- 5 years are reported by both, from 2018 to 2022.
- How do Jordan and United Arab Emirates rank globally for share of e. coli infections resistant to cephalosporins?
- Jordan ranks 14th and United Arab Emirates ranks 17th of 46 countries.
- Where does this data come from?
- World Health Organization – processed by Our World in Data, published as Share of E. coli infections resistant to cephalosporins. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%).